Meghmani Organics balance sheet

As of Mar 2026

Total assets: ₹3,021cr−2.1% on Mar 2025
Shareholders' equity: ₹1,545cr+1.9% on Mar 2025
Total debt: ₹726cr−12.4% on Mar 2025
Cash and investments: ₹16.8cr−25.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,484	1,563	1,150	1,164
	78.5	77.1	509	346
	10.2	11.6	1.3	2.0
	8.6	5.5	12.6	9.9
	3.6	3.2	98.2	153
	19.4	15.9	11.0	11.6
	22.9	19.1	109	165
	101	58.7	44.8	46.3
	1,705	1,735	1,827	1,733
	529	599	517	652
	1.0	0.0	16.2	30.0
	672	567	433	523
	15.8	22.7	16.9	31.1
	9.7	8.5	3.4	1.6
	0.4	0.4	0.3	0.4
	27.5	34.9	87.9	89.3
	727	633	557	676
	60.1	111	138	138
	1,315	1,350	1,213	1,466
	3,021	3,085	3,040	3,198
Equity
	25.4	25.4	25.4	25.4
	1,519	1,490	1,502	1,644
	1,545	1,515	1,528	1,669
	1,545	1,515	1,528	1,669
Liabilities
	161	283	383	402
	4.4	9.5	12.4	18.6
	165	293	396	420
	23.6	15.7	16.9	15.8
	55.3	58.1	37.8	57.4
	—	0.0	5.9	5.9
	249	367	456	499
	565	546	452	419
	540	550	494	448
	79.8	63.8	78.8	130
	1,185	1,160	1,024	997
	2.6	1.7	0.2	0.2
	26.0	18.7	18.7	18.7
	12.8	23.1	13.2	14.1
	1,226	1,204	1,056	1,030
	1,476	1,570	1,512	1,529
	3,021	3,085	3,040	3,198
Assets — additional as-filed lines
	0.0	6.9	0.0	0.0
Liabilities — additional as-filed lines
	5.1	0.0	0.0	0.0
Trade payables — MSME split
	540	550	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MOL₹51.99

Meghmani Organics Limited

· Chemicals

₹ CrorePeersIPL PUNJABCHEM INSECTICID ASTEC BHARATRAS DHARMAJ GSPCROP ADVANCEMcap ₹1,322 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,164.1	1,150.3	1,563.3	1,483.8	1,483.8
+ Capital Work-in-Progress	345.6	508.6	77.1	78.5	78.5
+ Other Intangibles	2.0	1.3	11.6	10.2	10.2
+ Intangibles under Development	9.9	12.6	5.5	8.6	8.6
+ Non-current Investments	153.2	98.2	3.2	3.6	3.6
+ Other Non-current Financial Assets	11.6	11.0	15.9	19.4	19.4
Non-current Financial Assets	164.9	109.3	19.1	22.9	22.9
+ Other Non-current Assets	46.3	44.8	58.7	101.4	101.4
Total Non-current Assets	1,732.8	1,827.0	1,735.3	1,705.5	1,705.5
Current Assets
+ Inventories	651.7	517.2	599.0	528.5	528.5
+ Current Investments	30.0	16.2	0.0	1.0	1.0
+ Trade Receivables	523.4	432.9	566.8	672.1	672.1
+ Cash & Cash Equivalents	31.1	16.9	22.7	15.8	15.8
+ Other Bank Balances	1.6	3.4	8.5	9.7	9.7
+ Short-term Loans	0.4	0.3	0.4	0.4	0.4
+ Other Current Financial Assets	89.3	87.9	34.9	27.5	27.5
Current Financial Assets	675.8	557.5	633.2	726.5	726.5
+ Other Current Assets	138.2	138.5	111.0	60.1	60.1
Total Current Assets	1,465.7	1,213.1	1,350.1	1,315.1	1,315.1
Total Assets	3,198.4	3,040.1	3,085.4	3,020.6	3,020.6
Equity
+ Equity Share Capital	25.4	25.4	25.4	25.4	25.4
+ Other Equity / Reserves	1,643.8	1,502.3	1,489.8	1,519.3	1,519.3
Equity — Owners of Parent	1,669.2	1,527.7	1,515.3	1,544.8	1,544.8
Total Equity	1,669.2	1,527.7	1,515.3	1,544.8	1,544.8
Liabilities
+ Borrowings — Non-current	401.6	383.1	283.3	161.0	161.0
+ Other Non-current Financial Liab	18.6	12.4	9.5	4.4	4.4
Non-current Financial Liabilities	420.2	395.5	292.8	165.3	165.3
+ Provisions — Non-current	15.8	16.9	15.7	23.6	23.6
+ Deferred Tax Liabilities	57.4	37.8	58.1	55.3	55.3
+ Other Non-current Liabilities	5.9	5.9	0.0	—	—
Non-current Liabilities	499.2	456.2	366.6	249.3	249.3
+ Borrowings — Current	418.9	451.8	545.8	565.0	565.0
+ Trade Payables	447.8	493.5	550.5	540.2	540.2
+ Other Current Financial Liab	130.3	78.8	63.8	79.8	79.8
Current Financial Liabilities	997.0	1,024.1	1,160.0	1,185.0	1,185.0
+ Provisions — Current	0.2	0.2	1.7	2.6	2.6
+ Current Tax Liabilities	18.7	18.7	18.7	26.0	26.0
+ Other Current Liabilities	14.1	13.2	23.1	12.8	12.8
Current Liabilities	1,030.0	1,056.3	1,203.6	1,226.5	1,226.5
Total Liabilities	1,529.2	1,512.4	1,570.2	1,475.8	1,475.8
Total Equity & Liabilities	3,198.4	3,040.1	3,085.4	3,020.6	3,020.6
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.0	6.9	0.0	0.0
Liabilities — additional as-filed lines
+ Deferred Government Grants — Non-current	0.0	0.0	0.0	5.1	5.1
Trade Payables — MSME split
+ Dues to Other Creditors — Current	—	—	550.5	540.2	540.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.